Concepedia

Stephen L. DeAngelo

SL

Statistics

Publications

4

Citations

816

H-Index

4

Active since

2016

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

University of Notre Dame

Chinese University of Hong Kong

Ain Shams University

Stephen L. DeAngelo is an author at Harvard University specializing in ligand binding, ligand binding selectivity, and molecular recognition.

ORCID

Publications per year

2016–2025

4

Publications

4

Plasticity in binding confers selectivity in ligand-induced protein degradation

Radosław P. Nowak, Stephen L. DeAngelo, Dennis L. Buckley et al. · Nature Chemical Biology · 2018 · 631 citations

, , +14

Design and characterization of bivalent BET inhibitors

Minoru Tanaka, Justin M. Roberts, Hyuk‐Soo Seo et al. · Nature Chemical Biology · 2016 · 157 citations · Full text

, , +12

Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer

Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz et al. · Cancer Research · 2025 · 17 citations · Full text

, , +17

Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer

Stephen L. DeAngelo, Liang Zhao, Sofia Dziechciarz et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 11 citations · Full text

, , +17

1–4 of 4